Novavax given limited approval as booster New ATAGI advice permits Novavax for third dose and encourages those who had AstraZeneca as primary course to take mRNA booster.
How many people were ‘waiting for Novavax’? The approval of Novavax was long-awaited. Now its rollout is under way, newsGP assesses what response GPs are seeing on the ground.
Vaccine safety anxiety driving parents towards misinformation How can GPs help combat this trend and ensure these patients don’t fall victim to misinformation?
Booster protection wanes after four months – what does this mean for winter in Australia? The US CDC’s latest report on the durability of booster protection has found a more than 20% decline in effectiveness against emergency department encounters.
Concerns for under-vaccinated pregnant population Pregnant women remain cautious when it comes to the COVID-19 vaccine, but growing safety evidence should boost uptake.
Novavax rollout fast-tracked After months of delays, the rollout of Australia’s fourth COVID vaccine began over the weekend.
Government spending on general practice surges Despite the funding rise general practice expenditure remains a fraction of the amount received by public hospitals.
Novavax approval: what it means for GPs The TGA’s Professor John Skerritt hopes the availability of the new vaccine will push the vaccination rate in Australia even higher.
New resources to make COVID vaccine booking easier In addition to streamlining online vaccine bookings, GPs can better understand the system with a new RACGP self-directed learning activity.
Vaccination gap: Vulnerable communities left exposed as Omicron threatens Aboriginal and Torres Strait Islander COVID vaccination rates continue to lag the general population, with some areas still less than 50% fully vaccinated.